Cefisal-200 Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Cefixime trihydrate

Indications/Uses

URTI eg, bacterial pharyngitis, tonsilitis, otitis media, sinusitis; lower resp tract infections eg, acute bronchitis; UTI eg, acute uncomplicated cystitis & urethritis; uncomplicated gonorrhea.

Click to view Cefisal-200 detailed prescribing information

Dosage/Direction for Use

Adult 400 mg once daily or 200 mg every 12 hr. Uncomplicated cervical/urethral gonococcal infection 400 mg as single dose. Childn 8 mg/kg/day as single dose or in 2 divided doses as 4 mg/kg every 12 hr. Typhoid 15-20 mg/kg/day as single dose or divided into 2 equal doses every 12 hr for 7-14 days. Infection due to Strep pyogenes Administer therapeutic dosage for at least 10 days.

Click to view Cefisal-200 detailed prescribing information

Overdosage

View Cefisal-200 overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity to cephalosporins. Renal impairment w/ CrCl <60 mL/min.

Click to view Cefisal-200 detailed prescribing information

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Cefisal-200 detailed prescribing information

Special Precautions

Patients who have shown hypersensitivity to other medicines/drugs; penicillin-sensitive patients. Discontinue if allergic effect occurs. Patients w/ markedly impaired renal function. Prolonged use may result in overgrowth of non-susceptible organisms. Antibiotic-associated pseudomembranous colitis; discontinue if diarrhea occurs. Encephalopathy. Discontinue when severe cutaneous adverse reactions eg, TEN, SJS & DRESS occur. Drug-induced hemolytic anaemia, including severe cases w/ fatal outcome. Discontinue when acute renal failure including tubulointerstitial nephritis occurs. Renal impairment. Not to be used in pregnancy or lactation. Premature or newborn infant.

Click to view Cefisal-200 detailed prescribing information

Use In Pregnancy & Lactation

Click to view Cefisal-200 detailed prescribing information

Adverse Reactions

Diarrhea & stool changes; nausea, abdominal pain, dyspepsia, vomiting & flatulence; pseudomembranous colitis. Headache & dizziness. Hypersensitivity reactions in the form of rash, pruritus, urticaria, drug fever & arthralgia. Thrombocytopenia, leukopenia & eosinophilia; changes in liver & renal function tests. Genital pruritus & vaginitis.

Click to view Cefisal-200 detailed prescribing information

Drug Interactions

May enhance effects of coumarin-type anticoagulants eg, warfarin K, & prolonged prothrombin time w/ or w/o bleeding may occur. False +ve reaction for glucose in urine may occur w/ Benedict's or Fehling's soln or w/ Cu sulphate test tab. False +ve direct Coombs test.

Click to view Cefisal-200 detailed prescribing information

Storage

View Cefisal-200 storage conditions for details to ensure optimal shelf-life.

Description

View Cefisal-200 description for details of the chemical structure and excipients (inactive components).

Action

View Cefisal-200 mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Cephalosporins

ATC Classification

J01DD08 - cefixime ; Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.

Regulatory Classification

Presentation/Packing

Form

Cefisal-200 FC tab 200 mg

Packing/Price

30's (P74.52/film-coated tab)

Cefisal-200

cefixime

Manufacturer:

GXI

Distributor:

Metro Drug